Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'REVERSE-TRANSCRIPTASE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 4456 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Romano, L; Venturi, G; Vivarelli, A; Galli, L; Zazzi, M
      Detection of a drug-resistant human immunodeficiency virus variant in a newly infected heterosexual couple

      CLINICAL INFECTIOUS DISEASES
    2. Raulin, J
      Human immunodeficiency virus and host cell lipids. Interesting pathways inresearch for a new HIV therapy

      PROGRESS IN LIPID RESEARCH
    3. Devereux, HL; Burke, A; Lee, CA; Johnson, MA
      In vivo HIV-1 compartmentalisation: Drug resistance-associated mutation distribution

      JOURNAL OF MEDICAL VIROLOGY
    4. Brincat, JL; Pfeiffer, JK; Telesnitsky, A
      RNase H activity is required for high-frequency repeat deletion during moloney murine leukemia virus replication

      JOURNAL OF VIROLOGY
    5. Casimiro, DR; Tang, AM; Perry, HC; Long, RS; Chen, MC; Heidecker, GJ; Davies, ME; Freed, DC; Persaud, NV; Dubey, S; Smith, JG; Havlir, D; Richman, D; Chastain, MA; Simon, AJ; Fu, TM; Emini, EA; Shiver, JW
      Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene

      JOURNAL OF VIROLOGY
    6. Lawler, JF; Merkulov, GV; Boeke, JD
      A nucleocapsid functionality contained within the amino terminus of the Ty1 protease that is distinct and separable from proteolytic activity

      JOURNAL OF VIROLOGY
    7. Lacroix, J; Doeberitz, MV
      Technical aspects of minimal residual disease detection in carcinoma patients

      SEMINARS IN SURGICAL ONCOLOGY
    8. Kienle, P; Koch, M
      Minimal residual disease in gastrointestinal cancer

      SEMINARS IN SURGICAL ONCOLOGY
    9. Ghossein, RA; Bhattacharya, S
      Molecular detection and characterization of circulating tumor cells and micrometastases in prostatic, urothelial, and renal cell carcinomas

      SEMINARS IN SURGICAL ONCOLOGY
    10. Grandin, N; Charbonneau, M
      Hsp90 levels affect telomere length in yeast

      MOLECULAR GENETICS AND GENOMICS
    11. Pifferi, A; Camalli, M; Silvestri, R; De Martino, G; Massa, S; Artico, M
      1-Amino-6-chloro-2-(1H-pyrrol-2-yl)benzimidazole (RS 1350)

      ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
    12. Cho, YK; Sung, H; Lee, HJ; Joo, CH; Cho, GJ
      Long-term intake of Korean red ginseng in HIV-1-infected patients: development of resistance mutation to zidovudine is delayed

      INTERNATIONAL IMMUNOPHARMACOLOGY
    13. Olivero, OA; Reddy, MK; Pietras, SM; Poirier, MC
      Plasma drug levels compared with DNA incorporation of 3'-azido-3'-deoxythymidine (AZT) in adult cynomolgus (Macaca fascicularis) monkeys

      EXPERIMENTAL BIOLOGY AND MEDICINE
    14. Lee, K; Chong, YH; Chu, CK
      Understanding the mode of action of L-nucleosides as antiviral agents: A molecular modeling approach

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    15. Bryant, ML; Bridges, EG; Placidi, L; Faraj, A; Loi, AG; Pierra, C; Dukhan, D; Gosselin, G; Imbach, JL; Hernandez, B; Juodawlkis, A; Tennant, B; Korba, B; Cote, P; Cretton-Scott, E; Schinazi, RF; Sommadossi, JP
      Anti-HBV specific beta-L-2 '-deoxynucleosides

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    16. Naeger, LK; Margot, NA; Miller, MD
      Tenofovir (PMPA) is less susceptible to pyrophosphorolysis and nucleotide-dependent chain-terminator removal than zidovudine or stavudine

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    17. Lobaton, E; Velazquez, S; Perez-Perez, MJ; Jimeno, ML; San-Felix, A; De Clercq, E; Balzarini, J; Camarasa, MJ
      "Second generation" of TSAO compounds directed against HIV-1 TSAO-resistant strains

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    18. Lobaton, E; Velazquez, S; San-Felix, A; De Clercq, E; Balzarini, J; Camarasa, MJ
      4 ''-H-TSAO-T, a novel prototype in the HIV-1 specific TSAO family

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    19. Noronha, AM; Arion, D; Parniak, MA; Damha, MJ
      Effect of substituting arabinonucleosides for deoxynucleotides in the DNA priming strand on the polymerase action of HIV-1 RT

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    20. Yamaguchi, T; Yamada, R; Tomikawa, A; Shudo, K; Saito, M; Ishikawa, F; Saneyoshi, M
      Inhibition of human telomerase by L-enantiomers of natural 2 '-deoxyribonucleoside 5 '-triphosphates

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    21. Akeb, F; Creminon, C; Grassi, J; Guedj, R; Duval, D
      The production and evaluation of antibodies for enzyme immunoassay of AZTTP

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    22. Belostotskii, AM; Keren-Yeshuah, H; Lexner, J; Hassner, A
      New 3 '-deoxythymidines bearing a nucleophilic 3 '-substituent

      NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
    23. Kyriakides, TC; Heimer, RR
      Development and application of a genotypic AZT resistance assay - Quantitative assessment of the resistance profile of clinical samples and the relative predictive ability of a resistance index

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    24. Stuart, JWTC; Wensing, AMJ; Kovacs, C; Righart, M; de Jong, D; Kaye, S; Schuurman, R; Visser, CJT; Boucher, CAB
      Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    25. Rakotoambinina, B; Medioni, J; Rabian, C; Jubault, V; Jais, JP; Viard, JP
      Lipodystrophic syndromes and hyperlipidemia in a cohort of HIV-1-infected patients receiving triple combination antiretroviral therapy with a protease inhibitor

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    26. Miller, MD; Margot, NA; Lamy, PD; Fuller, MD; Anton, KE; Mulato, AS; Cherrington, JM
      Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: Genotypic and phenotypic analyses of study GS-96-408

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    27. Roberts, DE; Ribeiro, RM
      Comparison of different treatment regimens for the emergence of new resistance under therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    28. Shulman, NS; Machekano, RA; Shafer, RW; Winters, MA; Zolopa, AR; Liou, SH; Hughes, M; Katzenstein, DA
      Genotypic correlates of a virologic response to stavudine after zidovudinemonotherapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    29. Bogner, JR; Vielhauer, V; Beckmann, RA; Michl, G; Wille, L; Salzberger, B; Goebel, FD
      Stavudine versus zidovudine and the development of lipodystrophy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    30. Ungsedhapand, C; Kroon, EDMB; Suwanagool, S; Ruxrungtham, K; Yimsuan, N; Sonjai, A; Ubolyam, S; Buranapraditkun, S; Tiengrim, S; Pakker, N; Kunanusont, C; Lange, JMA; Cooper, DA; Phanuphak, P
      A randomized, open-label, comparative trial of zidovudine plus lamivudine versus zidovudine plus lamivudine plus didanosine in antiretroviral-naive HIV-1-infected Thai patients

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    31. Mulligan, K; Tai, VW; Algren, H; Abrams, DI; Leiser, RJ; Lo, JC; Schambelan, M
      Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    32. Weidle, PJ; Kityo, CM; Mugyenyi, P; Downing, R; Kebba, A; Pieniazek, D; Respess, R; Hertogs, K; De Vroey, V; Dehertogh, P; Bloor, S; Larder, B; Lackritz, E
      Resistance to antiretroviral therapy among patients in Uganda

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    33. Duwe, S; Brunn, M; Altmann, D; Hamouda, O; Schmidt, B; Walter, H; Pauli, G; Kucherer, C
      Frequency of genotypic and phenotypic drug-resistant HIV-1 among therapy-naive patients of the German Seroconverter Study

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    34. Briones, C; Perez-Olmeda, M; Rodriguez, C; del Romero, J; Hertogs, K; Soriano, V
      Primary genotypic and phenotypic HIV-1 drug resistance in recent seroconverters in Madrid

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    35. Rousseau, MN; Vergne, L; Montes, B; Peeters, M; Reynes, J; Delaporte, E; Segondy, M
      Patterns of resistance mutations to antiretroviral drugs in extensively treated HIV-1-Infected patients with failure of highly active antiretroviral therapy

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    36. Becker, SL; Raffanti, SR; Hansen, NI; Fusco, JS; Fusco, GP; Slatko, GH; Igboko, EF; Graham, NMH
      Zidovudine and stavudine sequencing in HIV treatment planning: Findings from the CHORUS HIV cohort

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    37. Reisler, RB; Thea, DM; Pliner, V; Green, T; Lee, F; Nesheim, S; Brown, T; Kalish, M; Folks, TM; Heneine, W
      Early detection of reverse transcriptase activity in plasma of neonates infected with HIV-1: A comparative analysis with RNA-based and DNA-based testing using polymerase chain reaction

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    38. Demeter, L; Haubrich, R
      Phenotypic and genotypic resistance assays: Methodology, reliability, and interpretations

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    39. Loveday, C
      Nucleoside reverse transcriptase inhibitor resistance

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    40. Miller, V
      Resistance to protease inhibitors

      JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
    41. Maijgren-Steffensson, C; Sonnerborg, A; Vahlne, A; Britton, S; Larsson, S; Ahrlund-Richter, L
      Smaller amounts of antiretroviral drugs are needed when combined with an active ribozyme against HIV-1

      MOLECULAR THERAPY
    42. Paquette, LA; Bibart, RT; Seekamp, CK; Kahane, AL
      Spirocyclic restriction of nucleosides. Synthesis of the first exemplary syn-1-oxaspiro[4.4]nonanyl member

      ORGANIC LETTERS
    43. Aggarwal, VK; de Vicente, J; Bonnert, RV
      Catalytic cyclopropanation of alkenes using diazo compounds generated in situ. A novel route to 2-arylcyclopropylamines

      ORGANIC LETTERS
    44. Hiyama, E; Hiyama, K; Yokoyama, T; Shay, JW
      Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues

      NEOPLASIA
    45. Vekshin, N; Savintsev, I; Kovalev, A; Yelemessov, R; Wadkins, RM
      Solvatochromism of the excitation and emission spectra of 7-aminoactinomycin D: Implications for drug recognition of DNA secondary structures

      JOURNAL OF PHYSICAL CHEMISTRY B
    46. Olsen, AG; Nielsen, C; Wengel, J
      Synthesis and evaluation of anti-HIV activity of 3-azido-4-(hydroxymethyl)tetrahydrofuran derivatives containing 2-(thymin-1-yl)methyl, 2-(cytosin-1-yl)methyl or 2-(adenin-9-yl)methyl substituents - a new series of AZT analogues

      JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1
    47. Negroni, M; Buc, H
      Retroviral recombination: what drives the switch?

      NATURE REVIEWS MOLECULAR CELL BIOLOGY
    48. Holmes, EC
      On the origin and evolution of the human immunodeficiency virus (HIV)

      BIOLOGICAL REVIEWS
    49. Huang, A; Hindle, KS; Tsavellas, G
      Colorectal cancer surveillance post-surgery

      HOSPITAL MEDICINE
    50. Iorgulescu, DG; Kiroff, GK
      Minimal residual marrow disease: Detection and significance of isolated tumour cells in bone marrow

      ANZ journal of surgery
    51. Buck, C; Walsh, C; Davis, R; Toumadje, A; Kusamoto, K; Helmrich, A; Chapline, C; Mericko, P; Barnes, D
      Cell cultures and retroviral particles from a tumor of a moray eel

      MARINE BIOTECHNOLOGY
    52. Bianco, A; Celona, D; Di Rita, S; Guiso, M; Melchioni, C; Umani, F
      Chiral synthons from the iridoid glucoside antirrhinoside - Synthesis of acarbocyclic homonucleoside analogue

      EUROPEAN JOURNAL OF ORGANIC CHEMISTRY
    53. Surnmerer, D; Marx, A
      DNA polymerase selectivity: Sugar interactions monitored with high-fidelity nucleotides

      ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
    54. Ettorre, A; Silvestri, R; Artico, M; Massa, S; La Colla, P
      Crystal structure of 7-chloropyrrolo[1,2-b][1,2,5]benzothiadiazepin-10(11H)-one-5,5-dioxide, C11H7N2O3ClS

      ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES
    55. Tasara, T; Hottiger, MO; Hubscher, U
      Functional genomics in HIV-1 virus replication: Protein-protein interactions as a basis for recruiting the host cell machinery for viral propagation

      BIOLOGICAL CHEMISTRY
    56. Flepp, M; Schiffer, V; Weber, R; Hirschel, B
      Modern anti-HIV therapy

      SWISS MEDICAL WEEKLY
    57. Wilhelm, M; Wilhelm, FX
      Reverse transcription of retroviruses and LTR retrotransposons

      CELLULAR AND MOLECULAR LIFE SCIENCES
    58. Pereira, AS; Tidwell, RR
      Separation methods for nucleoside analogues used for treatment of HIV-1 infection

      JOURNAL OF CHROMATOGRAPHY B
    59. Sarasa-Nacenta, M; Lopez-Pua, Y; Lopez-Cortes, LF; Mallolas, J; Gatell, JM; Carne, X
      Determination of efavirenz in human plasma by high-performance liquid chromatography with ultraviolet detection

      JOURNAL OF CHROMATOGRAPHY B
    60. Gahan, ME; Miller, F; Lewin, SR; Cherry, CL; Hoy, JF; Mijch, A; Rosenfeldt, F; Wesselingh, SL
      Quantification of mitochondrial DNA in peripheral blood mononuclear cells and subcutaneous fat using real-time polymerase chain reaction

      JOURNAL OF CLINICAL VIROLOGY
    61. Arens, M
      Clinically relevant sequence-based genotyping of HBV, HCV, CMV, and HIV

      JOURNAL OF CLINICAL VIROLOGY
    62. Merour, JY; Joseph, B
      Synthesis and reactivity of 7-azaindoles (1H-pyrrolo[2,3-b]pyridine)

      CURRENT ORGANIC CHEMISTRY
    63. Kislyi, VV; Samet, AV; Semenov, VV
      The utility of nitroacetic acid and its derivatives in the synthesis of heterocycles

      CURRENT ORGANIC CHEMISTRY
    64. Ferrer, M; Sanchez-Lamar, A; Fuentes, JL; Barbe, J; Llagostera, M
      Studies on the antimutagenesis of Phyllanthus orbicularis: mechanisms involved against aromatic amines

      MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS
    65. Sumida, T; Hamakawa, H
      Telomerase and oral cancer

      ORAL ONCOLOGY
    66. Kijak, GH; Avila, MM; Salomon, H
      Mother-to-child transmission of drug-resistant HIV

      DRUG RESISTANCE UPDATES
    67. Plettenberg, A; Albrecht, D; Lorenzen, T; Paech, V; Petersen, H; Fenner, T; Meyer, T; Arndt, R; Hertogs, K; Pauwels, R; Weitzel, T; Stoehr, A
      Resistance analyses in HIV infected patients with a history of multiple antiretroviral treatment regimens

      SEXUALLY TRANSMITTED INFECTIONS
    68. White, AJ
      Mitochondrial toxicity and HIV therapy

      SEXUALLY TRANSMITTED INFECTIONS
    69. Bashiardes, S; Lovett, M
      cDNA detection and analysis

      CURRENT OPINION IN CHEMICAL BIOLOGY
    70. Chow, JFC; Lee, KF; Chan, STH; Yeung, WSB
      Quantification of transforming growth factor beta 1 (TGF beta(1)) mRNA expression in mouse preimplantation embryos and determination of TGF beta receptor (type I and type II) expression in mouse embryos and reproductive tract

      MOLECULAR HUMAN REPRODUCTION
    71. Gartland, M
      AVANTI 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients

      ANTIVIRAL THERAPY
    72. Rozenbaum, W; Katlama, C; Massip, P; Bentata, M; Zucman, D; Delfraissy, JF; Trepo, C; David, F; Lanier, ER; Vavro, C; Mamet, JP
      Treatment intensification with abacavir in HIV-infected patients with at least 12 weeks previous lamivudine/zidovudine treatment

      ANTIVIRAL THERAPY
    73. Buss, N; Cammack, N
      Measuring the effectiveness of antiretroviral agents

      ANTIVIRAL THERAPY
    74. Vandamme, AM; Houyez, F; Banhegyi, D; Clotet, B; De Schrijver, G; De Smet, KAL; Hall, WW; Harrigan, R; Hellmann, N; Hertogs, K; Holtzer, C; Larder, B; Pillay, D; Race, E; Schmit, JC; Schuurman, R; Shulse, E; Sonnerborg, A; Miller, V
      Laboratory guidelines for the practical use of HIV drug resistance tests in patient follow-up

      ANTIVIRAL THERAPY
    75. Rusconi, S; Catamancio, SL; Citterio, P; Bulgheroni, E; Kurtagic, S; Galazzi, M; Croce, F; Moroni, M; Galli, M
      Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine

      ANTIVIRAL THERAPY
    76. Foudraine, NA; Jurriaans, S; Weverling, GJ; Burger, DM; Hoetelmans, RMW; Roos, MTL; Maas, J; Miedema, F; Reiss, P; Portegies, P; de Wolf, F; Lange, JMA
      Durable HIV-1 suppression with indinavir after failing lamivudine-containing double nucleoside therapy: a randomized controlled trial

      ANTIVIRAL THERAPY
    77. Van Vaerenbergh, K; Debaisieux, L; De Cabooter, N; Declercq, C; Desmet, K; Fransen, K; Maes, B; Marissens, D; Miller, K; Muyldermans, G; Sprecher, S; Stuyver, L; Vaira, D; Verhofstede, C; Zissis, G; Van Ranst, M; De Clercq, E; Desmyter, J; Vandamme, AM
      Prevalence of genotypic resistance among antiretroviral drug-naive HTV-1-infected patients in Belgium

      ANTIVIRAL THERAPY
    78. Kijak, GH; Pampuro, SE; Avila, MM; Zala, C; Cahn, P; Wainberg, MA; Salomon, H
      Resistance profiles to antiretroviral drugs in HIV-1 drug-naive patients in Argentina

      ANTIVIRAL THERAPY
    79. Squires, KE
      An introduction to nucleoside and nucleotide analogues

      ANTIVIRAL THERAPY
    80. Pillay, D
      The emergence and epidemiology of resistance in the nucleoside-experiencedHIV-infected population

      ANTIVIRAL THERAPY
    81. Miller, V; Larder, BA
      Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure

      ANTIVIRAL THERAPY
    82. Miller, V
      Interpretation of resistance assay results

      ANTIVIRAL THERAPY
    83. Mallal, S
      Resistance and other factors involved in therapy failure

      ANTIVIRAL THERAPY
    84. Hoetelmans, R
      Pharmacological exposure and the development of drug resistance in HIV

      ANTIVIRAL THERAPY
    85. Kruger, WH; Jung, R; Detlefsen, B; Mumme, S; Badbaran, A; Brandner, J; Renges, H; Kroger, N; Zander, AR
      Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells

      MEDICAL ONCOLOGY
    86. Ford, LP; Shay, JW; Wright, WE
      The La antigen associates with the human telomerase ribonucleoprotein and influences telomere length in vivo

      RNA-A PUBLICATION OF THE RNA SOCIETY
    87. Makeyev, EV; Bamford, DH
      Primer-independent RNA sequencing with bacteriophage phi 6 RNA polymerase and chain terminators

      RNA-A PUBLICATION OF THE RNA SOCIETY
    88. Purohit, P; Dupont, S; Stevenson, M; Green, MR
      Sequence-specific interaction between HIV-1 matrix protein and viral genomic RNA revealed by in vitro genetic selection

      RNA-A PUBLICATION OF THE RNA SOCIETY
    89. Foxley, GL; Dong, QH; Handelsman, DJ
      Quantitative reverse transcriptase polymerase chain reaction assay for mouse androgen receptor mRNA

      ENDOCRINE
    90. Wang, L; Xie, LP; Zhang, RQ
      Gene expression of gonadotropin-releasing hormone and its receptor in rat pancreatic cancer cell lines

      ENDOCRINE
    91. Korbonits, M; Kojima, M; Kangawa, K; Grossman, AB
      Presence of ghrelin in normal and adenomatous human pituitary

      ENDOCRINE
    92. Garcia-Viejo, MA; Ruiz, M; Martinez, E
      Strategies for treating HIV-related lipodystrophy

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    93. Stojiljkovic, I; Evavold, BD; Kumar, V
      Antimicrobial properties of porphyrins

      EXPERT OPINION ON INVESTIGATIONAL DRUGS

    94. Phenylthiourea compounds for treating HIV infection - Parker Hughes Institute: WO0078721

      EXPERT OPINION ON THERAPEUTIC PATENTS

    95. Novel antiviral agents: phosphoramidates or mono/di/tri-phosphate esters of carbocyclic adenosine analogues

      EXPERT OPINION ON THERAPEUTIC PATENTS

    96. Benzophenones as inhibitors of reverse transcriptase - Glaxo Group Ltd.: WO117982

      EXPERT OPINION ON THERAPEUTIC PATENTS
    97. Borderi, M; Verucchi, G; Tadolini, M; Spinosa, S; Fortunato, L; Talo, S; Chiodo, F
      Metabolic complications of HIV-1 antiretroviral therapy: The lipodystrophysyndrome

      MICROBIOLOGICA
    98. Murray, HL; Mikheeva, S; Coljee, VW; Turczyk, BM; Donahue, WF; Bar-Shalom, A; Jarrell, KA
      Excision of group II introns as circles

      MOLECULAR CELL
    99. Das, M; Harvey, I; Chu, LL; Sinha, M; Pelletier, J
      Full-length cDNAs: more than just reaching the ends

      PHYSIOLOGICAL GENOMICS
    100. Ramachandran, C; Melnick, SJ; Escalon, E; Khatib, Z; Jhabvala, P; Fonseca, HB; Smith, S; Alamo, A; Medina, S
      Cytogenetic and molecular characterization of a congenital mesoblastic nephroma

      PEDIATRIC AND DEVELOPMENTAL PATHOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 26/02/20 alle ore 04:26:01